Skip to main content
Log in

Treatment of hepatocellular carcinoma: A single-center experience

  • Clinical Investigations
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

The comparative efficacy of transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) in the treatment of hepatocellular carcinoma (HCC) was investigated.

Methods

Two hundred and sixty consecutive patients were retrospectively analyzed: 156 had received between one and six chemoembolization sessions at 3-month intervals, 33 had had PEI, and the remaining 71 patients refused any treatment. The follow-up ranged from 3 to 36 months. Survival rates were statistically analyzed by life-table analysis.

Results

Patients’ survival was affected by the number of nodules and by the Child’s and Okuda’s classes; no relationship was found between survival rates and the histologic grade or vascular supply of the tumor. In the case of a single lesion of Okuda’s class I, TACE was more effective than PEI. In multifocal HCC, TACE was better than no treatment in Okuda’s class I and Child’s class A.

Conclusion

We suggest TACE as the treatment of choice in Child A or Okuda I patients with multifocal HCCs; it seems of little help in Child B-C or Okuda II–III patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adachi E, Matsumata T, Nishizaki T, Hashimoto H, Tsuneyashi M, Sugimachi K (1993) Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 72:3593–3598

    Article  PubMed  CAS  Google Scholar 

  2. Beppu T, Ohara C, Yamaguchi Y, Ichihara T, Yamanaka T, Katafuchi S, Ikei S, Mori K, Fukushima S, Nakano M, Ogawa M (1991) A new approach to chemoembolization for unresectable hepatocellular carcinoma using aclarubicin microspheres in combination with cisplatin suspended in iodized oil. Cancer 68: 2555–2560

    Article  PubMed  CAS  Google Scholar 

  3. Bronowicki JP, Vetter D, Dumas F, Boudjema K, Pader R, Weis AM, Wenger JJ, Boissel P, Bigard MA, Doffoel M (1994) Transcatheter oily chemoembolization for hepatocellular carcinoma: A 4-year study of 127 French patients. Cancer 74:16–24

    Article  PubMed  CAS  Google Scholar 

  4. Levin B, Amos C (1995) Therapy of unresectable hepatocellular carcinoma. N Engl J Med 332:1294–1296

    Article  PubMed  CAS  Google Scholar 

  5. Livraghi T, Solbiati L (1993) Percutaneous ethanol injection in liver cancer: Method and results. Semin Intervent Radiol 10: 69–77

    Google Scholar 

  6. Nakano S, Haratake J, Okamoto K, Takeda S (1994) Investigation of resected multinodular hepatocellular carcinoma: Assessment of unicentric or multicentric genesis from histological and prognostic viewpoint. Am J Gastroenterol 89:189–193

    PubMed  CAS  Google Scholar 

  7. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Ohnishi K (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 56:918–928

    Article  PubMed  CAS  Google Scholar 

  8. Peracchia A, Bolondi L, Colombo M, Corinaldesi A, Cottone M, Grigioni W, Livraghi T, Mazziotti A, Rossi C, Suraci V (1993) Terapia del carcinoma epatocellulare. Gastroenterol Int (Ed Ital) 4:197–206

    Google Scholar 

  9. Rossi P, Salvatori F, D’Erme M, Maradei A, Rossi M, Santoro P, Mastantuono M, Gualdi G (1989) Terapia degli epatocarcinomi mediante iniezione intra-arteriosa di Lipiodol-Antiblastici e Gelfoam. Radiol Med 77:37–43

    CAS  PubMed  Google Scholar 

  10. Savastano S, Feltrin GP, Miotto D, Chiesura Corona M, Torraco A, Castellan L, Romani E, Khatib AB, Cannito F, Sandri P (1992) La chemioembolizzazione nella terapia dell’epatocarcinoma: Esperienza di 3 anni. Radiol Med 84:608–612

    CAS  PubMed  Google Scholar 

  11. Tanaka K, Nakamura S, Numata K, Okazaki H, Endo O, Inoue S, Takamura Y, Sugiyama M, Ohaki Y (1992) Hepatocellular carcinoma: Treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 185:457–460

    PubMed  CAS  Google Scholar 

  12. Tang ZY, Fiorentini G (1993) Hepatoma today: Therapeutic experiences of multimodal approach. Tumori 79:166–169

    PubMed  CAS  Google Scholar 

  13. Trevisani F, D’Intimo PE, Caraceni P, Pizzo M, Stefanini GF (1995) Etiologic factors and clinical presentation of hepatocellular carcinoma: Differences between cirrhotic and noncirrhotic Italian patients. Cancer 75:2220–2232

    Article  PubMed  CAS  Google Scholar 

  14. Shiina S, Tagawa K, Unuma T, Terano A (1990) Percutaneous ethanol injection therapy of hepatocellular carcinoma: Analysis of 77 patients. AJR 155:1221–1226

    PubMed  CAS  Google Scholar 

  15. Shiina S, Niwa Y, Omata M (1993) Percutaneous ethanol injection therapy for liver neoplasm. Semin Intervent Radiol 10: 57–68

    Article  Google Scholar 

  16. Florio F, Nardella M, Balzano S, Parracino T, Siena D, Caturelli E, Andriulli A, Cammisa M (1993) Epatocarcinoma primitivo: Diagnostica per immagini e chemioembolizzazione. Radiol Med 86:478–483

    CAS  PubMed  Google Scholar 

  17. Charnsangavej C (1993) Chemoembolization of liver tumors. Semin Intervent Radiol 10:150–160

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Florio, F., Nardella, M., Balzano, S. et al. Treatment of hepatocellular carcinoma: A single-center experience. Cardiovasc Intervent Radiol 20, 23–28 (1997). https://doi.org/10.1007/s002709900104

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002709900104

Key words

Navigation